Clinical Trial Update: Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial of an angiotensin therapeutic vaccine for mild-to-moderate hypertension was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension

Drugs mentioned

• Angiotensin Therapeutic Vaccine

Snippet

Sponsor: BTG International Inc. | Conditions: Hypertension, Cardiovascular Disease | Phase 2 | Status: TERMINATED | Results posted: 2016-07-29